Veeda Lifesciences Teams Up with Mango Sciences for AI in Trials

Veeda Lifesciences Partners with Mango Sciences to Enhance Clinical Trials

Veeda Lifesciences, a leading contract research organization (CRO), has taken a significant step forward by investing in Mango Sciences, a data and AI technology company based in Boston. This strategic collaboration is set to revolutionize clinical trial services by integrating advanced AI capabilities, enabling a more efficient, speedy, and quality-driven approach to clinical research.

Transformative AI in Clinical Trials

Through this partnership, Veeda aims to harness the power of Mango Sciences' Querent™ platform. By leveraging this innovative technology, Veeda will automate patient identification with a high degree of accuracy, ultimately enhancing its ability to connect with global patient populations. This technology will not only boost operational efficiency but also broaden access to diverse patient demographics across various regions.

Addressing Diversity in Clinical Trials

The journey towards automation and digital transformation is particularly important in clinical trials. As Dr. Mahesh Bhalgat, Group CEO and Managing Director of Veeda Clinical Research Limited, emphasized, this partnership caters to the growing need for diversity in clinical research. With an increasing focus from regulators and pharmaceutical companies on inclusive practices, Veeda stands to become one of the few CROs specializing in oncology, equipped with proprietary technology.

Enhancing Operational Efficiencies

This collaboration is part of Veeda’s broader objective to modernize its technological framework. The integration of the Querent™ platform will streamline clinical processes, improve data management procedures, and maintain rigorous quality standards. By ensuring broader representation in clinical trials, particularly among non-Caucasian populations, the partnership promises to enhance the overall efficiency of clinical trials through improved patient matching, trial designs, and monitoring capabilities.

Innovations in Real-World Evidence

Dr. Mohit Misra, the Founder and CEO of Mango Sciences, highlighted the significance of integrating Large Language Models (LLMs) and Generative-AI into their Querent™ platform. This evolution is expected to propel operational efficiencies and bolster real-world evidence, ultimately optimizing patient care by matching the right treatments with the right individuals.

Strengthening Veeda’s Competitive Edge

Veeda has established itself as a tech-enabled, AI-driven leader in the CRO space through strategic investments and acquisitions, including a notable partnership with Health Data Specialists. This has positioned Veeda to access oncology cohorts both in India and globally, thereby enabling it to maintain a competitive advantage while serving clients in the pharmaceutical and biopharmaceutical sectors. The aim is to continue delivering high-quality services that meet the rigorous standards expected in today's rapidly evolving healthcare landscape.

About Veeda Lifesciences

Veeda Lifesciences offers a broad array of services that span the drug development continuum, tailored to support the needs of small and medium biotech and pharmaceutical companies. Its capabilities range from non-clinical and pre-clinical development to eventual clinical pharmacology and trials encompassing various modalities.

About Mango Sciences

Mango Sciences prides itself on its commitment to transforming patient care through innovative data analytics solutions. Founded by experts with rich backgrounds in healthcare and life sciences, Mango Sciences aims to enhance patient representation and improve access to healthcare through advanced analytics.

Frequently Asked Questions

1. What is the focus of the partnership between Veeda and Mango Sciences?

The partnership aims to integrate AI technology into clinical trials, enhancing the efficiency and diversity of patient recruitment.

2. Who are the leaders involved in this partnership?

Dr. Mahesh Bhalgat leads Veeda Lifesciences, while Dr. Mohit Misra heads Mango Sciences, both contributing their expertise to this collaboration.

3. How will the Querent™ platform improve clinical trials?

The Querent™ platform will automate patient identification, enhance data management, and ensure greater diversity in patient representation.

4. Why is diversity important in clinical trials?

Diversity in clinical trials ensures that the results are applicable to a broader population, improving the overall quality and relevance of the research.

5. What are Veeda's capabilities in drug development?

Veeda offers comprehensive services across the drug development value chain, catering to various sectors in the biotech and pharmaceutical industries.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.